Widening the Neuroimaging Features of Adenosine Deaminase 2 Deficiency.
Journal
AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
22
08
2020
accepted:
23
11
2020
pubmed:
27
2
2021
medline:
10
7
2021
entrez:
26
2
2021
Statut:
ppublish
Résumé
Adenosine deaminase 2 deficiency (OMIM #615688) is an autosomal recessive disorder characterized by a wide clinical spectrum, including small- and medium-sized vessel vasculopathies, but data focusing on the associated neuroimaging features are still scarce in the literature. Here, we describe the clinical neuroimaging features of 12 patients with genetically proven adenosine deaminase 2 deficiency (6 males; median age at disease onset, 1.3 years; median age at genetic diagnosis, 15.5 years). Our findings expand the neuroimaging phenotype of this condition demonstrating, in addition to multiple, recurrent brain lacunar ischemic and/or hemorrhagic strokes, spinal infarcts, and intracranial aneurysms, also cerebral microbleeds and a peculiar, likely inflammatory, perivascular tissue in the basal and peripontine cisterns. Together with early clinical onset, positive family history, inflammatory flares and systemic abnormalities, these findings should raise the suspicion of adenosine deaminase 2 deficiency, thus prompting genetic evaluation and institution of tumor necrosis factor inhibitors, with a potential great impact on neurologic outcome.
Identifiants
pubmed: 33632736
pii: ajnr.A7019
doi: 10.3174/ajnr.A7019
pmc: PMC8115359
doi:
Substances chimiques
Adenosine Deaminase
EC 3.5.4.4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
975-979Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 by American Journal of Neuroradiology.
Références
Rheumatology (Oxford). 2016 May;55(5):902-10
pubmed: 26867732
Eur J Pediatr. 2014 Jun;173(6):827-30
pubmed: 24737293
Clin Imaging. 2019 Jul - Aug;56:108-113
pubmed: 31029009
J Neuroradiol. 2019 May;46(3):193-198
pubmed: 29913178
N Engl J Med. 2014 Mar 6;370(10):921-31
pubmed: 24552285
Clin Rheumatol. 2020 Dec;39(12):3853-3860
pubmed: 32535845
Lancet Neurol. 2013 May;12(5):483-97
pubmed: 23602162
Neurology. 2015 May 19;84(20):2092-3
pubmed: 25888558
Arthritis Rheumatol. 2016 Sep;68(9):2314-22
pubmed: 27059682
Neurol Med Chir (Tokyo). 2012;52(12):928-32
pubmed: 23269053
BMC Res Notes. 2014 Feb 14;7:89
pubmed: 24529495
AJNR Am J Neuroradiol. 2017 Feb;38(2):218-229
pubmed: 27469212
J Rheumatol. 2020 Jan;47(1):117-125
pubmed: 31043544
Ann Rheum Dis. 2017 Oct;76(10):1648-1656
pubmed: 28522451
Neuropediatrics. 2017 Apr;48(2):111-114
pubmed: 28024309
Lancet Neurol. 2015 Sep;14(9):914-925
pubmed: 26184985
Rev Med Interne. 2018 Apr;39(4):297-306
pubmed: 29273180
N Engl J Med. 2014 Jul 31;371(5):478-80
pubmed: 25075847
J Stroke Cerebrovasc Dis. 2018 Aug;27(8):e168-e171
pubmed: 29602618
N Engl J Med. 2014 Mar 6;370(10):911-20
pubmed: 24552284
Rheumatol Int. 2018 Jan;38(1):129-136
pubmed: 28516235
J Allergy Clin Immunol. 2020 Jun;145(6):1664-1672.e10
pubmed: 31945408